Skip to main content
Top
Published in: Journal of Cardiovascular Magnetic Resonance 1/2010

Open Access 01-12-2010 | Technical notes

Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy

Authors: Stephan Fluechter, Jürgen Kuschyk, Christian Wolpert, Christina Doesch, Christian Veltmann, Dariusch Haghi, Stefan O Schoenberg, Tim Sueselbeck, Tjeerd Germans, Florian Streitner, Martin Borggrefe, Theano Papavassiliu

Published in: Journal of Cardiovascular Magnetic Resonance | Issue 1/2010

Login to get access

Abstract

Background

Myocardial fibrosis is frequently identified in patients with hypertrophic cardiomyopathy (HCM). The aim of this study was to investigate the role of myocardial fibrosis detected by late gadolinium-enhancement (LGE) cardiovascular magnetic resonance (CMR) as a potential arrhythmogenic substrate in HCM. We hypothesized that the extent of LGE might be associated with the inducibility of ventricular tachyarrhythmias (VT) during programmed ventricular stimulation (PVS).

Methods

We evaluated retrospectively LGE CMR of 76 consecutive HCM patients, of which 43 presented with one or more risk factors for sudden cardiac death (SCD) and were therefore clinically classified as high-risk patients. Of these 43 patients, 38 additionally underwent an electrophysiological testing (EP). CMR indices and the extent of LGE, given as the % of LV mass with LGE were correlated with the presence of risk factors for SCD and the results of EP.

Results

High-risk patients had a significant higher prevalence of LGE than low-risk patients (29/43 [67%] versus 14/33 [47%]; p = 0.03). Also the % of LV mass with LGE was significantly higher in high-risk patients than in low-risk patients (14% versus 3%, p = 0.001, respectively). Of the 38 high- risk patients, 12 had inducible VT during EP. LV function, volumes and mass were comparable in patients with and without inducible VT. However, the % of LV mass with LGE was significantly higher in patients with inducible VT compared to those without (22% versus 10%, p = 0.03). The prevalence of LGE was, however, comparable between HCM patients with and those without inducible VT (10/12 [83%] versus 15/26 [58%]; p = 0.12). In the univariate analysis the % of LV mass with LGE and the septal wall thickness were significantly associated with the high-risk group (p = 0.001 and 0.004, respectively). Multivariate analysis demonstrated that the extent of LGE was the only independent predictor of the risk group (p = 0.03).

Conclusions

The extent of LGE in HCM patients correlated with risk factors of SCD and the likelihood of inducible VT. Furthermore, LGE extent was the only independent predictor of the risk group. This supports the hypothesis that the extent of fibrosis may serve as potential arrhythmogenic substrate for the occurrence of VT, especially in patients with clinical risk factors for SCD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Maron BJ, Shen WK, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA, Spirito P: Efficacy of Implantable Cardioverter-Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy. N Engl J Med. 2000, 342: 365-373. 10.1056/NEJM200002103420601.CrossRefPubMed Maron BJ, Shen WK, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA, Spirito P: Efficacy of Implantable Cardioverter-Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy. N Engl J Med. 2000, 342: 365-373. 10.1056/NEJM200002103420601.CrossRefPubMed
2.
go back to reference Priori SG, Aliot E, Blomstrom-Lundqvist , Bossaert L, Breithardt G, Brugada P, Camm JA, Cappato R, Cobbe SM, Di Mario C, Maron BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJ, Zipes DP: Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J. 2001, 22: 1374-450. 10.1053/euhj.2001.2824.CrossRefPubMed Priori SG, Aliot E, Blomstrom-Lundqvist , Bossaert L, Breithardt G, Brugada P, Camm JA, Cappato R, Cobbe SM, Di Mario C, Maron BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJ, Zipes DP: Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J. 2001, 22: 1374-450. 10.1053/euhj.2001.2824.CrossRefPubMed
3.
go back to reference Monserrat L, Elliott PM, Gimero JR, Sharma S, Penas-Lado M, McKenna WJ: Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol. 2003, 42: 873-9. 10.1016/S0735-1097(03)00827-1.CrossRefPubMed Monserrat L, Elliott PM, Gimero JR, Sharma S, Penas-Lado M, McKenna WJ: Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol. 2003, 42: 873-9. 10.1016/S0735-1097(03)00827-1.CrossRefPubMed
4.
go back to reference Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ: Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005, 45: 697-704. 10.1016/j.jacc.2004.11.043.CrossRefPubMed Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ: Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005, 45: 697-704. 10.1016/j.jacc.2004.11.043.CrossRefPubMed
5.
go back to reference Maron BJ, Lipson LC, Roberts WC, Savage DD, Epstein SE: "Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. Am J Cardiol. 1978, 41: 1133-40. 10.1016/0002-9149(78)90870-6.CrossRefPubMed Maron BJ, Lipson LC, Roberts WC, Savage DD, Epstein SE: "Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. Am J Cardiol. 1978, 41: 1133-40. 10.1016/0002-9149(78)90870-6.CrossRefPubMed
6.
go back to reference Spirito P, Bellone P, Harris KM, Bernabò P, Bruzzi P, Maron BJ: Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000, 342: 1778-85. 10.1056/NEJM200006153422403.CrossRefPubMed Spirito P, Bellone P, Harris KM, Bernabò P, Bruzzi P, Maron BJ: Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000, 342: 1778-85. 10.1056/NEJM200006153422403.CrossRefPubMed
7.
go back to reference Hurwitz JL, Josephson ME: Sudden cardiac death in patients with chronic coronary heart disease. Circulation. 1992, 85: 43-49. Hurwitz JL, Josephson ME: Sudden cardiac death in patients with chronic coronary heart disease. Circulation. 1992, 85: 43-49.
8.
go back to reference Callans DJ, Josephson ME: Ventricular tachycardia in patients with coronary artery disease. Cardiac Electrophysiology: From Cell To Bedside. Edited by: Zipes DP, Jalife J. 2000, Philadelphia, Saunders, 530-536. Callans DJ, Josephson ME: Ventricular tachycardia in patients with coronary artery disease. Cardiac Electrophysiology: From Cell To Bedside. Edited by: Zipes DP, Jalife J. 2000, Philadelphia, Saunders, 530-536.
9.
go back to reference Saumarez RC, Camm AJ, Panagos A, Gill JS, Stewart JT, de Belder MA, Simpson IA, McKenna WJ: Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms. Circulation. 1992, 86: 467-474.CrossRefPubMed Saumarez RC, Camm AJ, Panagos A, Gill JS, Stewart JT, de Belder MA, Simpson IA, McKenna WJ: Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms. Circulation. 1992, 86: 467-474.CrossRefPubMed
10.
go back to reference Cripps TR, Counihan PJ, Frenneaux MP, Ward DE, Camm AJ, McKenna WJ: Signal-averaged electrocardiography in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1990, 15: 956-961. 10.1016/0735-1097(90)90223-C.CrossRefPubMed Cripps TR, Counihan PJ, Frenneaux MP, Ward DE, Camm AJ, McKenna WJ: Signal-averaged electrocardiography in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1990, 15: 956-961. 10.1016/0735-1097(90)90223-C.CrossRefPubMed
11.
go back to reference Saumarez RC, Pytkowski M, Sterlinski M, Bourke JP, Clague JR, Cobbe SM, Connelly DT, Griffith MJ, McKeown PP, McLeod K, Morgan JM, Sadoul N, Chojnowska L, Huang CL, Grace AA: Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy. Eur Heart J. 2008, 29: 1653-61. 10.1093/eurheartj/ehn111.CrossRefPubMed Saumarez RC, Pytkowski M, Sterlinski M, Bourke JP, Clague JR, Cobbe SM, Connelly DT, Griffith MJ, McKeown PP, McLeod K, Morgan JM, Sadoul N, Chojnowska L, Huang CL, Grace AA: Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy. Eur Heart J. 2008, 29: 1653-61. 10.1093/eurheartj/ehn111.CrossRefPubMed
12.
go back to reference Kim RJ, Judd RM: Gadolinium-Enhanced magnetic resonance imaging in hypertrophic cardiomyopathy In vivo imaging of the pathologic substrate for premature cardiac death?. J Am Coll Cardiol. 2003, 41: 1568-1572. 10.1016/S0735-1097(03)00190-6.CrossRefPubMed Kim RJ, Judd RM: Gadolinium-Enhanced magnetic resonance imaging in hypertrophic cardiomyopathy In vivo imaging of the pathologic substrate for premature cardiac death?. J Am Coll Cardiol. 2003, 41: 1568-1572. 10.1016/S0735-1097(03)00190-6.CrossRefPubMed
13.
go back to reference Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ: The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004, 43: 2260-2264. 10.1016/j.jacc.2004.03.035.CrossRefPubMed Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ: The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004, 43: 2260-2264. 10.1016/j.jacc.2004.03.035.CrossRefPubMed
14.
go back to reference Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, Bonow RO, Judd RM, Kim RJ: Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Card. 2002, 40: 2156-2164. 10.1016/S0735-1097(02)02602-5.CrossRef Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, Bonow RO, Judd RM, Kim RJ: Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Card. 2002, 40: 2156-2164. 10.1016/S0735-1097(02)02602-5.CrossRef
15.
go back to reference Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ: Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003, 41: 1561-1567. 10.1016/S0735-1097(03)00189-X.CrossRefPubMed Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ: Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003, 41: 1561-1567. 10.1016/S0735-1097(03)00189-X.CrossRefPubMed
16.
go back to reference Teraoka K, Hirano M, Ookubo H, Sasaki K, Katsuyama H, Amino M, Abe Y, Yamashina A: Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging. 2004, 22: 155-61. 10.1016/j.mri.2003.08.009.CrossRefPubMed Teraoka K, Hirano M, Ookubo H, Sasaki K, Katsuyama H, Amino M, Abe Y, Yamashina A: Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging. 2004, 22: 155-61. 10.1016/j.mri.2003.08.009.CrossRefPubMed
17.
go back to reference Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS: Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol. 2008, 51: 1369-74. 10.1016/j.jacc.2007.11.071.CrossRefPubMed Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS: Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol. 2008, 51: 1369-74. 10.1016/j.jacc.2007.11.071.CrossRefPubMed
18.
go back to reference Dimitrow PP, Klimeczek P, Vliegenthart R, Pasowicz M, Oudkerk M, Podolec P, Tracz W, Dubiel JS: Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia. Int J Cardiovasc Imaging. 2008, 24: 77-83. 10.1007/s10554-007-9209-9.CrossRefPubMed Dimitrow PP, Klimeczek P, Vliegenthart R, Pasowicz M, Oudkerk M, Podolec P, Tracz W, Dubiel JS: Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia. Int J Cardiovasc Imaging. 2008, 24: 77-83. 10.1007/s10554-007-9209-9.CrossRefPubMed
19.
go back to reference Maron BJ: Hypertrophic cardiomyopathy: A Systematic Review. JAMA. 2002, 287: 1308-1320. 10.1001/jama.287.10.1308.PubMed Maron BJ: Hypertrophic cardiomyopathy: A Systematic Review. JAMA. 2002, 287: 1308-1320. 10.1001/jama.287.10.1308.PubMed
20.
go back to reference Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED: American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J. 2003, 24: 1965-91. 10.1016/S0195-668X(03)00479-2.CrossRefPubMed Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED: American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J. 2003, 24: 1965-91. 10.1016/S0195-668X(03)00479-2.CrossRefPubMed
21.
go back to reference Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM: An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001, 218: 215-23.CrossRefPubMed Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM: An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001, 218: 215-23.CrossRefPubMed
22.
go back to reference Kellman P, Arai AE, McVeigh ER, Aletras AH: Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med. 2002, 47: 372-83. 10.1002/mrm.10051.PubMedCentralCrossRefPubMed Kellman P, Arai AE, McVeigh ER, Aletras AH: Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med. 2002, 47: 372-83. 10.1002/mrm.10051.PubMedCentralCrossRefPubMed
23.
go back to reference Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B: American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006, 8: 746-837. 10.1093/europace/eul108.CrossRefPubMed Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B: American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006, 8: 746-837. 10.1093/europace/eul108.CrossRefPubMed
24.
go back to reference Fananapazir L, Chang AC, Epstein SE, McAreavey D: Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation. 1992, 86: 730-40.CrossRefPubMed Fananapazir L, Chang AC, Epstein SE, McAreavey D: Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation. 1992, 86: 730-40.CrossRefPubMed
25.
go back to reference Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, Gerstenblith G, Weiss RG, Marbán E, Tomaselli GF, Lima JA, Wu KC: Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007, 115: 2006-2014. 10.1161/CIRCULATIONAHA.106.653568.PubMedCentralCrossRefPubMed Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, Gerstenblith G, Weiss RG, Marbán E, Tomaselli GF, Lima JA, Wu KC: Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007, 115: 2006-2014. 10.1161/CIRCULATIONAHA.106.653568.PubMedCentralCrossRefPubMed
26.
go back to reference Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G, Kadish AH, Goldberger JJ: Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol. 2005, 45: 1104-1108. 10.1016/j.jacc.2004.12.057.CrossRefPubMed Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G, Kadish AH, Goldberger JJ: Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol. 2005, 45: 1104-1108. 10.1016/j.jacc.2004.12.057.CrossRefPubMed
27.
go back to reference Nazarian S, Bluemke DA, Lardo AC, Zviman MM, Watkins SP, Dickfeld TL, Meininger GR, Roguin A, Calkins H, Tomaselli GF, Weiss RG, Berger RD, Lima JA, Halperin HR: Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation. 2005, 112: 2821-2825. 10.1161/CIRCULATIONAHA.105.549659.PubMedCentralCrossRefPubMed Nazarian S, Bluemke DA, Lardo AC, Zviman MM, Watkins SP, Dickfeld TL, Meininger GR, Roguin A, Calkins H, Tomaselli GF, Weiss RG, Berger RD, Lima JA, Halperin HR: Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation. 2005, 112: 2821-2825. 10.1161/CIRCULATIONAHA.105.549659.PubMedCentralCrossRefPubMed
28.
go back to reference Varnava AM, Elliott PM, Mahon N, Davies MJ, McKenna WJ: Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol. 2001, 88: 275-279. 10.1016/S0002-9149(01)01640-X.CrossRefPubMed Varnava AM, Elliott PM, Mahon N, Davies MJ, McKenna WJ: Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol. 2001, 88: 275-279. 10.1016/S0002-9149(01)01640-X.CrossRefPubMed
29.
go back to reference Bondarenko O, Beek AM, Hofman MB, Kühl HP, Twisk JW, van Dockum WG, Visser CA, van Rossum AC: Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. Journal of Cardiovascular Magnetic Resonance. 2005, 7: 481-5. 10.1081/JCMR-200053623.CrossRefPubMed Bondarenko O, Beek AM, Hofman MB, Kühl HP, Twisk JW, van Dockum WG, Visser CA, van Rossum AC: Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. Journal of Cardiovascular Magnetic Resonance. 2005, 7: 481-5. 10.1081/JCMR-200053623.CrossRefPubMed
Metadata
Title
Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy
Authors
Stephan Fluechter
Jürgen Kuschyk
Christian Wolpert
Christina Doesch
Christian Veltmann
Dariusch Haghi
Stefan O Schoenberg
Tim Sueselbeck
Tjeerd Germans
Florian Streitner
Martin Borggrefe
Theano Papavassiliu
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Cardiovascular Magnetic Resonance / Issue 1/2010
Electronic ISSN: 1532-429X
DOI
https://doi.org/10.1186/1532-429X-12-30

Other articles of this Issue 1/2010

Journal of Cardiovascular Magnetic Resonance 1/2010 Go to the issue